SRC-mediated phosphorylation of UBC9 regulates inflammatory and metabolic signaling in alcohol-associated liver disease
Science Advances · 2026
DOI: 10.1126/sciadv.aec0138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Swati Chandla und 14 weiteren Autor:innen. Beteiligte Einrichtung: Karsh Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048 USA. Hauptthemen laut MEDLINE: Signal Transduction, Liver Diseases, Alcoholic, src-Family Kinases, Ubiquitin-Conjugating Enzymes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, National Institutes of Health, Cedars Sinai Medical Center.
Abstract (Originalsprache)
Alcohol-associated liver disease (ALD) remains a major public health challenge with limited treatment options. NF-κB–driven inflammation in Kupffer cells (KCs) plays a central role in ALD, but the upstream regulators remain poorly understood. Here, we identify the tyrosine kinase SRC as a key mediator of ALD. Chronic ethanol exposure activates SRC in KCs, which directly phosphorylates ubiquitin-conjugating enzyme 9 (UBC9), the only E2 SUMO enzyme, at tyrosine-68 (Y68). This modification enhances NF-κB signaling and increases proinflammatory cytokines (TNF-α, IL-6, and IL-1β). These cytokines then promote hepatic lipogenesis through SREBP1c- and CEBPβ-dependent induction of FASN and ACC. Inhibition of UBC9 phosphorylation by gene editing or SRC inhibitor reduces NF-κB–dependent inflammation and lessens ethanol-induced liver injury in mouse models. These findings uncover a previously unrecognized SRC–UBC9–NF-κB axis that drives inflammation in ALD and highlight it as a potential therapeutic target in liver disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Karsh Division of Gastroenterology and Hepatology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048 USA.
- Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA 90048 USA.
- Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA 90048 USA.
- Department of General Surgery, Guys and St Thomas Hospital, London SE1 7EH, UK.
ORCID-Profile: Swati Chandla, Youngyi Lim, Michael Mazarei, Takashi Tsuchiya, Alfonso Darmawan, Ramachandran Murali, Nirmala Mavila, Komal Ramani, Maria Lauda Tomasi
Förderung
- NIAAA NIH HHS
- National Institutes of Health
- Cedars Sinai Medical Center
Zitieren
APA
Chandla, S., Lim, Y., Floris, A., Mazarei, M., Yang, X., Tsuchiya, T., Dagar, M., Darmawan, A., Justo, M., Murali, R., Gangi, A., Tomasi, I., Mavila, N., Ramani, K., & Tomasi, M. L. (2026). SRC-mediated phosphorylation of UBC9 regulates inflammatory and metabolic signaling in alcohol-associated liver disease. Science Advances. https://doi.org/10.1126/sciadv.aec0138
Vancouver
Chandla S, Lim Y, Floris A, Mazarei M, Yang X, Tsuchiya T, et al. SRC-mediated phosphorylation of UBC9 regulates inflammatory and metabolic signaling in alcohol-associated liver disease. Science Advances. 2026. doi:10.1126/sciadv.aec0138
BibTeX
@article{Chandla2026,
author = {Chandla, Swati and Lim, Youngyi and Floris, Andrea and Mazarei, Michael and Yang, Xi and Tsuchiya, Takashi and Dagar, Manisha and Darmawan, Alfonso and Justo, Monica and Murali, Ramachandran and Gangi, Alexandra and Tomasi, Ivan and Mavila, Nirmala and Ramani, Komal and Tomasi, Maria Lauda},
title = {SRC-mediated phosphorylation of UBC9 regulates inflammatory and metabolic signaling in alcohol-associated liver disease},
journal = {Science Advances},
year = {2026},
doi = {10.1126/sciadv.aec0138}
}
EUVIMED